These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 16927595)
1. [Paliperidone]. Oberpichler-Schwenk H Med Monatsschr Pharm; 2006 Aug; 29(8):280-2. PubMed ID: 16927595 [No Abstract] [Full Text] [Related]
2. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia. Jones A J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670 [TBL] [Abstract][Full Text] [Related]
3. Paliperidone overdose in a patient with schizophrenia. Chang JP; Huang CC; Su KP Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588 [No Abstract] [Full Text] [Related]
4. Molecule of the month. Paliperidone. Drug News Perspect; 2007 Jun; 20(5):333. PubMed ID: 17878961 [No Abstract] [Full Text] [Related]
5. A randomized, double-blind, placebo-controlled study of 2 dose ranges of paliperidone extended-release in the treatment of subjects with schizoaffective disorder. Canuso CM; Lindenmayer JP; Kosik-Gonzalez C; Turkoz I; Carothers J; Bossie CA; Schooler NR J Clin Psychiatry; 2010 May; 71(5):587-98. PubMed ID: 20492853 [TBL] [Abstract][Full Text] [Related]
6. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia. Fowler JA; Bettinger TL; Argo TR Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262 [TBL] [Abstract][Full Text] [Related]
7. Paliperidone (Invega) for schizophrenia. Med Lett Drugs Ther; 2007 Mar; 49(1256):21-3. PubMed ID: 17351558 [No Abstract] [Full Text] [Related]
8. Use of paliperidone in elderly patients with schizophrenia and schizoaffective disorder: a prospective open-label short-term pilot study. Madhusoodanan S; Brenner R; Serper MR; Adelsky M; Adler DN J Clin Psychopharmacol; 2011 Jun; 31(3):380-2. PubMed ID: 21532366 [No Abstract] [Full Text] [Related]
9. Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. Angelucci F; Ricci V; Martinotti G; Caltagirone C; Bria P Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1277-8. PubMed ID: 19555731 [No Abstract] [Full Text] [Related]
10. [Efficacy, tolerability and safety of paliperidone extended-release in the treatment of schizophrenia and schizoaffective disorder]. Bellantuono C; Santone G Riv Psichiatr; 2012; 47(1):5-20. PubMed ID: 22358213 [TBL] [Abstract][Full Text] [Related]
11. [Treatment with paliperidone extended-release tablets in a case of resistant undifferentiated schizophrenia: clinical improvement with 12 mg and evaluation through 3TRE scale]. Rusconi AC; Carlone C; Muscillo M; Piccione M Riv Psichiatr; 2009; 44(4):267-72. PubMed ID: 20066799 [TBL] [Abstract][Full Text] [Related]
12. Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder. Liang CS; Yang FW; Huang YC J Clin Psychopharmacol; 2012 Oct; 32(5):720-1. PubMed ID: 22926613 [No Abstract] [Full Text] [Related]
13. Paliperidone extended-release for the treatment of schizophrenia. Marino J; Caballero J Pharmacotherapy; 2008 Oct; 28(10):1283-98. PubMed ID: 18823223 [TBL] [Abstract][Full Text] [Related]
14. Paliperidone: quo vadis? Citrome L Int J Clin Pract; 2007 Apr; 61(4):653-62. PubMed ID: 17343660 [TBL] [Abstract][Full Text] [Related]
15. Paliperidone in the treatment of Tourette's syndrome with comorbid schizophrenia. Guan CH; Tsai SJ Psychiatry Clin Neurosci; 2013 Feb; 67(2):128. PubMed ID: 23438169 [No Abstract] [Full Text] [Related]